Literature DB >> 20096368

IAP antagonists: promising candidates for cancer therapy.

Raimund Mannhold1, Simone Fulda, Emanuele Carosati.   

Abstract

A promising strategy in cancer therapy aims to promote apoptosis in cancer cells. Targeting inhibitor of apoptosis proteins (IAPs) with small-molecule inhibitors has attracted increasing interest in triggering cancer cell death. It is considered to have great potential for cancer drug discovery because IAPs block apoptosis at the core of the apoptotic machinery and are aberrantly expressed in various tumors. This review focuses on the current development of small-molecule IAP antagonists for cancer therapy. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20096368     DOI: 10.1016/j.drudis.2010.01.003

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  30 in total

1.  A potent bivalent Smac mimetic (SM-1200) achieving rapid, complete, and durable tumor regression in mice.

Authors:  Rong Sheng; Haiying Sun; Liu Liu; Jianfeng Lu; Donna McEachern; Guanfeng Wang; Jianfeng Wen; Ping Min; Zhenyun Du; Huirong Lu; Sanmao Kang; Ming Guo; Dajun Yang; Shaomeng Wang
Journal:  J Med Chem       Date:  2013-05-07       Impact factor: 7.446

2.  A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment.

Authors:  Qian Cai; Haiying Sun; Yuefeng Peng; Jianfeng Lu; Zaneta Nikolovska-Coleska; Donna McEachern; Liu Liu; Su Qiu; Chao-Yie Yang; Rebecca Miller; Han Yi; Tao Zhang; Duxin Sun; Sanmao Kang; Ming Guo; Lance Leopold; Dajun Yang; Shaomeng Wang
Journal:  J Med Chem       Date:  2011-03-28       Impact factor: 7.446

Review 3.  Apoptotic cell signaling in cancer progression and therapy.

Authors:  Jessica Plati; Octavian Bucur; Roya Khosravi-Far
Journal:  Integr Biol (Camb)       Date:  2011-02-22       Impact factor: 2.192

4.  RAF inhibition overcomes resistance to TRAIL-induced apoptosis in melanoma cells.

Authors:  Anja Berger; Sandra-Annika Quast; Michael Plötz; Nicholas-Frederik Kuhn; Uwe Trefzer; Jürgen Eberle
Journal:  J Invest Dermatol       Date:  2013-08-16       Impact factor: 8.551

5.  Design, synthesis and evaluation of monovalent Smac mimetics that bind to the BIR2 domain of the anti-apoptotic protein XIAP.

Authors:  Marcos González-López; Kate Welsh; Darren Finlay; Robert J Ardecky; Santhi Reddy Ganji; Ying Su; Hongbin Yuan; Peter Teriete; Peter D Mace; Stefan J Riedl; Kristiina Vuori; John C Reed; Nicholas D P Cosford
Journal:  Bioorg Med Chem Lett       Date:  2011-05-24       Impact factor: 2.823

6.  Therapeutic potential and molecular mechanism of a novel, potent, nonpeptide, Smac mimetic SM-164 in combination with TRAIL for cancer treatment.

Authors:  Jianfeng Lu; Donna McEachern; Haiying Sun; Longchuan Bai; Yuefeng Peng; Su Qiu; Rebecca Miller; Jinhui Liao; Han Yi; Meilan Liu; Anita Bellail; Chunhai Hao; Shi-Yong Sun; Adrian T Ting; Shaomeng Wang
Journal:  Mol Cancer Ther       Date:  2011-03-03       Impact factor: 6.261

7.  Role of Apollon in human melanoma resistance to antitumor agents that activate the intrinsic or the extrinsic apoptosis pathways.

Authors:  Elena Tassi; Marina Zanon; Claudia Vegetti; Alessandra Molla; Ilaria Bersani; Valentina Perotti; Marzia Pennati; Nadia Zaffaroni; Michele Milella; Soldano Ferrone; Carmelo Carlo-Stella; Alessandro M Gianni; Roberta Mortarini; Andrea Anichini
Journal:  Clin Cancer Res       Date:  2012-05-02       Impact factor: 12.531

8.  Design, synthesis and evaluation of inhibitor of apoptosis protein (IAP) antagonists that are highly selective for the BIR2 domain of XIAP.

Authors:  Robert J Ardecky; Kate Welsh; Darren Finlay; Pooi San Lee; Marcos González-López; Santhi Reddy Ganji; Palaniyandi Ravanan; Peter D Mace; Stefan J Riedl; Kristiina Vuori; John C Reed; Nicholas D P Cosford
Journal:  Bioorg Med Chem Lett       Date:  2013-05-14       Impact factor: 2.823

Review 9.  Anti-cancer IAP antagonists promote bone metastasis: a cautionary tale.

Authors:  Chang Yang; Deborah Veis Novack
Journal:  J Bone Miner Metab       Date:  2013-06-06       Impact factor: 2.626

10.  Structural insights into a HECT-type E3 ligase AREL1 and its ubiquitination activities in vitro.

Authors:  Sunil Singh; Joel Ng; Digant Nayak; J Sivaraman
Journal:  J Biol Chem       Date:  2019-11-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.